Literature DB >> 7115962

Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia.

A T Look, S L Melvin, D L Williams, G M Brodeur, G V Dahl, D K Kalwinsky, S B Murphy, A M Mauer.   

Abstract

Cellular DNA content distributions of propidium-iodide-stained bone marrow blasts were determined by flow cytometry (FCM) for 225 untreated children with acute leukemia and were correlated with leukemia cell phenotype and karyotype. Aneuploidy of the primary malignant stem line was detected in 54 cases (24%): 51 hyperdiploid and 3 hypodiploid. A second stem line with approximately twice the DNA content of the primary stem line was recognized by FCM in 28 cases (23 ALL, 5 ANLL) and may be an important source of leukemia cell heterogeneity. The degree of DNA content abnormality detected by FCM was highly correlated (r = 0.98) with the number of whole chromosome gains or losses in the leukemia karyotype. Aneuploidy detectable by FCM was more frequent in acute lymphoblastic leukemia (ALL) (52 of 173, 30.1%) than in acute nonlymphoblastic leukemia (2 of 52, 3.8%) (p less than 0.001). In the ALL group, aneuploidy was significantly correlated with the cell surface expression of common ALL antigen: 46 of 127 antigen-positive cases were aneuploid compared to 6 of 46 antigen-negative cases (p less than 0.003). Only 2 of 21 cases of T-cell ALL without common ALL antigen had detectable aneuploidy, which was significantly less than in the common ALL group (p = 0.02). The median percentage of cells in S-phase was significantly greater for B-cell and erythrocyte rosette-positive T-cell ALL, than for the other phenotypic subgroups. We conclude that aneuploidy and S-phase cell percentage are correlated with the state of leukemia cell differentiation. The biologic basis for the correlation is not established, but may be linked to the process of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115962

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Cellular DNA content and histopathological analysis in hepatocellular carcinoma with multiple nodules.

Authors:  N Ichikawa; J Fujimoto; E Okamoto; N Yamanaka; T Nishigami
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

Authors:  H S Goh; J R Jass; W S Atkin; J Cuzick; J M Northover
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

Review 3.  The use of the clinical immunology laboratory.

Authors:  S H Yoshida; B C Veit; L E Mansfield; M E Gershwin
Journal:  Clin Rev Allergy       Date:  1994

4.  Current issues in the management of children with acute lymphocytic leukaemia.

Authors:  D Pinkel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 5.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.

Authors:  A T Look; S L Melvin; L K Brown; M E Dockter; P K Roberson; S B Murphy
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.

Authors:  T Bösing; A Roessner; W Hiddemann; W Mellin; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry.

Authors:  A Neubauer; H Sauer; G Valet
Journal:  Blut       Date:  1987-11

9.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

10.  Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders.

Authors:  N de Melo; E Matutes; I Cordone; R Morilla; D Catovksy
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.